13F filer · CIK 1065521 ↗
SoftBank Group
You are looking at Q2 2025. See the latest, Q2 2026 →
Reported value
$24.94B
−15% on the quarter before
Positions
27
4 new · 1 sold out
Top 10
96.1%
of the value
Est. gain
+$1.18B
on stocks held all quarter
Est. return
+5.0%
on those stocks since Q1 2025
Positions as of Jun 30, 2025, from SoftBank Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2025. Striped tiles are options.
Largest buys
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Chime Finl Inc~$174.9MNew · 0.0% → 0.7%+5,067,336 shares
- Metsera Inc~$137.1MNew · 0.0% → 0.5%+4,819,884 shares
- Etoro Group Ltd~$26.5MNew · 0.0% → 0.1%+397,998 shares
- Satellogic~$9.3MNew · 0.0% → 0.0%+2,582,645 shares
Largest sells
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- T-Mobile Us~$5.12BCut · 77.7% → 61.0%−21,500,000 shares
- Lemonade~$196.9MCut · 1.1% → 1.0%−4,493,778 shares
- Satellogic~$9.2MSold out · 0.0% → 0.0%−2,582,645 shares
- Full Truck Alliance Co Ltd~$6.0MCut · 0.1% → 0.1%−506,965 shares
Holdings
As of Jun 30, 2025. Changes are in shares against Mar 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| T-Mobile UsCOM · shares −25% · price −10.7% | 61.0% | $15.22B | −$1.82B | ||||||||
| NvidiaCOM · shares 0% · price +45.8% | 19.3% | $4.82B | +$1.51B | ||||||||
| SymboticCLASS A COM · shares 0% · price +92.2% | 6.2% | $1.55B | +$742.3M | ||||||||
| Inter & Co ICLASS A CO · shares 0% · price +35.6% | 1.9% | $479.3M | +$125.8M | ||||||||
| TSMCSPONSORED ADS · shares 0% · price +36.4% | 1.8% | $449.6M | +$120.1M | ||||||||
| Tempus AICL A · shares 0% · price +31.7% | 1.4% | $343.5M | +$82.8M | ||||||||
| Nu Hldgs LORD SHS CL · shares 0% · price +34.0% | 1.2% | $288.2M | +$73.1M | ||||||||
| Webtoon Entmt IncCOM · shares 0% · price +18.4% | 1.1% | $285.4M | +$44.3M | ||||||||
| OracleCOM · shares 0% · price +56.4% | 1.1% | $266.7M | +$96.2M | ||||||||
| LemonadeCOM · shares −43% · price +39.4% | 1.0% | $261.1M | +$73.8M | ||||||||
| VtexSHS CL A · shares 0% · price +30.2% | 1.0% | $253.7M | +$58.8M | ||||||||
| Chime Finl IncCOM SHS CL A · shares New | 0.70% | $174.9M | — | ||||||||
| Metsera IncCOM · shares New | 0.55% | $137.1M | — | ||||||||
| Qxo IncCOM NEW · shares 0% · price +59.1% | 0.47% | $117.8M | +$43.8M | ||||||||
| Recursion Pharmaceuticals InCL A · shares 0% · price −4.3% | 0.30% | $74.2M | −$3.4M | ||||||||
| Cipher Mining IncCOM · shares 0% · price +107.8% | 0.20% | $49.9M | +$25.9M | ||||||||
| Afya LtdCL A COM · shares 0% · price −0.4% | 0.17% | $43.5M | −$170,332 | ||||||||
| Full Truck Alliance Co LtdSPONSORED ADS · shares −16% · price −7.5% | 0.12% | $30.9M | −$2.5M | ||||||||
| Etoro Group LtdSHS CL A · shares New | 0.11% | $26.5M | — | ||||||||
| Pacific Biosciences Calif InCOM · shares 0% · price +5.1% | 0.10% | $25.4M | +$1.2M | ||||||||
| Seer IncCOM CL A · shares 0% · price +26.6% | 0.04% | $11.0M | +$2.3M | ||||||||
| SatellogicCLASS A OR · shares New | 0.04% | $9.3M | — | ||||||||
| Better Home & Finance HoldinCOM NEW CL A · shares 0% · price +13.5% | 0.03% | $7.8M | +$927,116 | ||||||||
| Globalstar IncCOM · shares 0% · price +12.9% | 0.03% | $7.6M | +$863,498 | ||||||||
| Neumora Therapeutics Inc.COM · shares 0% · price −26.7% | 0.02% | $4.8M | −$1.7M | ||||||||
| Total · 27 positions | 100% | $24.94B | +$1.18B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2025 to Q2 2025: 23 stocks held throughout, up $1.18B (+5.0%).
- Nvidia+$1.51B+46%
- Symbotic+$742.3M+92%
- Inter & Co I+$125.8M+36%
- TSMC+$120.1M+36%
- Oracle+$96.2M+56%
- Neumora Therapeutics Inc.−$1.7M−27%
- Full Truck Alliance Co Ltd−$2.5M−8%
- Recursion Pharmaceuticals In−$3.4M−4%
- Ess Tech In−$4.6M−59%
- T-Mobile Us−$1.82B−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $18.17B+59% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $11.41B−26% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $15.47B−40% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $25.97B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $24.94B−15% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $29.31B+25% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $23.37B+6% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $21.95B−44% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 (amended) | $39.11B+105% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $19.06B+3% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $18.54B+6% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $17.56B+97% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.92B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $7.76B+16% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $6.66B−1% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $6.76B−14% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $7.83B−22% | SEC ↗ |
| Q1 2022 | Sep 21, 2022 (amended) | $9.99B−7% | SEC ↗ |
| Q4 2021 | Sep 21, 2022 (amended) | $10.75B−5% | SEC ↗ |
| Q3 2021 | Feb 22, 2022 (amended) | $11.26B−42% | SEC ↗ |
| Q2 2021 | Nov 15, 2021 (amended) | $19.33B+33% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $14.58B−9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $15.95B+23% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 | $12.92B−26% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $17.52B−41% | SEC ↗ |
| Q1 2020 | Oct 2, 2020 | $29.70B+65% | SEC ↗ |
| Q4 2019 | Oct 2, 2020 | $17.95B−16% | SEC ↗ |
| Q3 2019 | Oct 9, 2020 | $21.26B−6% | SEC ↗ |
| Q2 2019 | Oct 9, 2020 | $22.64B+16% | SEC ↗ |
| Q1 2019 | Oct 9, 2020 | $19.49B−3% | SEC ↗ |
| Q4 2018 | Oct 9, 2020 | $20.15B−11% | SEC ↗ |
| Q3 2018 | Oct 16, 2020 | $22.56B+21% | SEC ↗ |
| Q2 2018 | Oct 16, 2020 | $18.60B+11% | SEC ↗ |
| Q1 2018 | Oct 16, 2020 | $16.68B−16% | SEC ↗ |
| Q4 2017 | Oct 16, 2020 | $19.96B−23% | SEC ↗ |
| Q3 2017 | Oct 23, 2020 | $25.91B−17% | SEC ↗ |
| Q2 2017 | Oct 23, 2020 | $31.25B−2% | SEC ↗ |
| Q1 2017 | Oct 23, 2020 | $31.73B+3% | SEC ↗ |
| Q4 2016 | Oct 23, 2020 | $30.81B+40% | SEC ↗ |
| Q3 2016 | Oct 30, 2020 | $22.02B+45% | SEC ↗ |
| Q2 2016 | Oct 30, 2020 | $15.17B+30% | SEC ↗ |
| Q1 2016 | Oct 30, 2020 | $11.69B | SEC ↗ |